Rafferty Asset Management, LLC Harmony Biosciences Holdings, Inc. Transaction History
Rafferty Asset Management, LLC
- $27.6 Billion
- Q4 2024
A detailed history of Rafferty Asset Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 8,105 shares of HRMY stock, worth $299,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,105Holding current value
$299,641% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$245 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$216 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$175 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$84.3 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$58.4 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.19B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...